Lisa Lambie, MBA

Over 20+ years, Lisa Lambie has successfully founded and scaled institutional firms and ventures; establishing a track record globally as a transformative leader, astute institutional investor & arranger (US$30bn+), frequently invited keynote, and catalytic entrepreneur across private credit and growth equity (as both GP & Limited Partner). Lisa is the Managing Partner for Maroon Venture Fund I LP ~ a U.S venture capital / growth fund investing anchor capital to advance Healthy Aging, Healthspan & Longevity by closing material innovation and funding gaps in proactive, personalized Precision Medicine & Preventative Health for the early protocols, detection, diagnosis and reduction in chronic Population Health conditions; and mitigation of direct Climate Impact on Health. Fund is anchored by its Managing Partner and consortium of investor-operators. Team (collectively) has a strong track record in Fund investment thesis with $960mm AUM delivering 5x+ MOIC to limited partners and 36 realized venture exits.

Reflective of a successful multi-generational Family Business in Precision Medicine, Genetics & Integrative Medicine for the prevention of chronic Population Health conditions, Lisa is also the Non-Executive Chairman of Maroon Research Institute, headquartered in the US with operations in 12 countries globally advancing Healthspan & Longevity through Integrated & Precision Medicine accelerating successful innovation-commercialisation lifecycles for prevention of chronic health conditions prioritizing neurological & brain health; cardiovascular & blood health; respiratory health & environmental allergies; inflammation; and autoimmune disorders. The Institute pursues scientific innovation (e.g. biomarkers, genomics et al), and has less of a focus on sole "Lifestyle" prevention. In 2024, the Institute launched the hugely successful AstraWell Women's Health & Longevity initiative and venture studio (United Kingdom, USA), and in 2025 launched its Global Longevity Venture Studio 2.0.

David Luu, MD

Dr. David Luu is a longevity tech entrepreneur, cardiac surgeon, and philanthropist redefining how longevity medicine is practiced, scaled, and integrated across industries.

He is the founder of Longevity Doctors, a network that unites the world’s top longevity doctors to democratize longevity medicine.

Andrea Corleto

Andrea is an experienced entrepreneur dedicated to transforming women's health. As the Founder & CEO of Lyv Health, she is building a company focused on extending female healthspan — the years women spend in good health — through science-backed, personalized care.

A Harvard MBA candidate (Class of 2026) with a strong background in scaling consumer startups, Andrea has launched and grown brands from $0 to $200M+ in revenue. Before founding Lyv, she was an early hire and Head of Marketing at Skylight Frame, playing a key role in turning it into a household name. She also founded Silkkin, a consumer health brand that she bootstrapped to seven figures in revenue.

Andrea is one of only eight Guatemalan women to have attended Harvard Business School. Her journey from humble beginnings to global entrepreneurship has shaped her mission to close the gender gap in healthcare innovation. Growing up near a Blue Zone in Costa Rica inspired her early interest in healthy living and longevity — themes that continue to define her work today.

Earlier in her career, Andrea worked in Venture Capital and Private Equity, supporting founders and accelerator programs across the U.S. She is a member of Chief, a private network for executive women, and the Primary Ventures Executive Network.

Outside of work, Andrea is an equestrian, early-morning Pilates enthusiast, and avid traveler, having visited over 40 countries and lived in 12.